These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8962121)

  • 41. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice.
    Kollmann TR; Kim A; Pettoello-Mantovani M; Hachamovitch M; Rubinstein A; Goldstein MM; Goldstein H
    J Immunol; 1995 Jan; 154(2):907-21. PubMed ID: 7814892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreased immune activation in resistance to HIV-1 infection is associated with an elevated frequency of CD4(+)CD25(+)FOXP3(+) regulatory T cells.
    Card CM; McLaren PJ; Wachihi C; Kimani J; Plummer FA; Fowke KR
    J Infect Dis; 2009 May; 199(9):1318-22. PubMed ID: 19301980
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro susceptibility of Thai seronegative donor CD8+ T lymphocytes to human immunodeficiency virus-1 (HIV-1) infection.
    Haponsaph R; Darden JM; Chantakulkij S; Sannoi N; de Souza MS; Brown AE; Birx DL; Polonis VR; Pattanapanyasat K
    Asian Pac J Allergy Immunol; 2004 Mar; 22(1):39-48. PubMed ID: 15366657
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Innate Immune Reconstitution in Humanized Bone Marrow-Liver-Thymus (HuBLT) Mice Governs Adaptive Cellular Immune Function and Responses to HIV-1 Infection.
    Garcia-Beltran WF; Claiborne DT; Maldini CR; Phelps M; Vrbanac V; Karpel ME; Krupp KL; Power KA; Boutwell CL; Balazs AB; Tager AM; Altfeld M; Allen TM
    Front Immunol; 2021; 12():667393. PubMed ID: 34122425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Current humanized mouse models for studying human immunology and HIV-1 immuno-pathogenesis.
    Zhang L; Meissner E; Chen J; Su L
    Sci China Life Sci; 2010 Feb; 53(2):195-203. PubMed ID: 20596827
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Primary HIV-1 infection of human CD4+ T cells passaged into SCID mice leads to selection of chronically infected cells through a massive fas-mediated autocrine suicide of uninfected cells.
    Parlato S; Santini SM; Lapenta C; Spada M; Logozzi M; Rizza P; Proietti E; Belardelli F; Fais S
    Cell Death Differ; 2000 Jan; 7(1):37-47. PubMed ID: 10713719
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Vaccination with the Conserved Caveolin-1 Binding Motif in Human Immunodeficiency Virus Type 1 Glycoprotein gp41 Delays the Onset of Viral Infection and Provides Partial Protection in Simian/Human Immunodeficiency Virus-Challenged Cynomolgus Macaques.
    Hovanessian AG; Soundaramourty C; Benferhat R; Le Grand R; Dereuddre-Bosquet N; Krust B; Estaquier J
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proliferation of functional human natural killer cells with anti-HIV-1 activity in NOD/SCID/Jak3(null) mice.
    Hattori S; Matsuda K; Kariya R; Harada H; Okada S
    Microbiol Immunol; 2016 Feb; 60(2):106-13. PubMed ID: 26708420
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SCID-hu mice: a model for studying disseminated HIV infection.
    Goldstein H; Pettoello-Mantovani M; Katopodis NF; Kim A; Yurasov S; Kollmann TR
    Semin Immunol; 1996 Aug; 8(4):223-31. PubMed ID: 8883145
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of HIV-1-specific T-cell immune responses in highly HIV-exposed uninfected individuals by in-vitro dendritic cell co-culture.
    Guardo AC; Ruiz-Riol M; Fernández E; Maleno MJ; Bargalló ME; León A; Climent N; García F; Gatell JM; Brander C; Plana M
    AIDS; 2015 Jul; 29(11):1309-18. PubMed ID: 26091301
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice.
    Garaci E; Aquaro S; Lapenta C; Amendola A; Spada M; Covaceuszach S; Perno CF; Belardelli F
    Proc Natl Acad Sci U S A; 2003 Jul; 100(15):8927-32. PubMed ID: 12853577
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rapid evolution of HIV-1 to functional CD8⁺ T cell responses in humanized BLT mice.
    Dudek TE; No DC; Seung E; Vrbanac VD; Fadda L; Bhoumik P; Boutwell CL; Power KA; Gladden AD; Battis L; Mellors EF; Tivey TR; Gao X; Altfeld M; Luster AD; Tager AM; Allen TM
    Sci Transl Med; 2012 Jul; 4(143):143ra98. PubMed ID: 22814851
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transfer of human myocarditis into severe combined immunodeficiency mice.
    Schwimmbeck PL; Badorff C; Schultheiss HP; Strauer BE
    Circ Res; 1994 Jul; 75(1):156-64. PubMed ID: 8013075
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Protection of hu-PBL-SCID/beige mice from HIV-1 infection by a 6-mer modified oligonucleotide, R-95288.
    Agatsuma T; Abe K; Furukawa H; Koga R; Koizumi M; Hotoda H; Kaneko M
    Antiviral Res; 1997 May; 34(3):121-30. PubMed ID: 9191019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Systems biology-based approaches to understand HIV-exposed uninfected women.
    Burgener A; Sainsbury J; Plummer FA; Ball TB
    Curr HIV/AIDS Rep; 2010 May; 7(2):53-9. PubMed ID: 20425558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Resistance to HIV-1 infection among highly exposed sex workers in Nairobi: what mediates protection and why does it develop?
    Plummer FA; Ball TB; Kimani J; Fowke KR
    Immunol Lett; 1999 Mar; 66(1-3):27-34. PubMed ID: 10203031
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of protective immunity to HIV-1 in human PBL-SCID mice.
    Mosier DE
    Antibiot Chemother (1971); 1996; 48():125-30. PubMed ID: 8726515
    [No Abstract]   [Full Text] [Related]  

  • 59. Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals.
    Shacklett BL
    Curr HIV/AIDS Rep; 2006 Feb; 3(1):26-31. PubMed ID: 16522256
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunologic Control of HIV-1: What Have We Learned and Can We Induce It?
    Rogan DC; Connors M
    Curr HIV/AIDS Rep; 2021 Jun; 18(3):211-220. PubMed ID: 33709324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.